Tag: SUMMIT MAX
Route 92 completes enrolment in 250-patient SUMMIT MAX trial
Route 92 Medical has today announced the completion of enrolment in the 250-patient SUMMIT MAX clinical trial evaluating the safety and effectiveness of its...
Route 92’s Monopoint operating platform shows 82% first-pass effect in independent...
Route 92 Medical recently announced the publication of an investigator-initiated, multicentre SLIC (Super large-bore ingestion of clot) study of its proprietary Monopoint operating platform,...
Route 92 Medical announces first patient enrolment in SUMMIT MAX pivotal...
Route 92 Medical has announced the first patient enrolment in its SUMMIT MAX clinical trial—a randomised, controlled, multicentre study to evaluate the performance of...
